Lung cancer survival rates are up thanks to immunotherapy ...
Apr 12, 2024 · Lung cancer remains the most lethal form of the disease, killing about 135,000 Americans a year – more than breast, prostate and colon cancer combined – which is why many people still think of...
US lung cancer survival rates rise, but it’s still the ...
Nov 14, 2023 · CNN — Over the past five years, the five-year survival rate for lung cancer in the US has increased a significant 22%, according to a new report from the American Lung Association. But the...
Osimertinib Improves Survival in Lung Cancer - NCI
Jul 5, 2023 · Highly anticipated results from a large study of people with early-stage lung cancer are generating praise, and some controversy, among oncologists who specialize in treating people with this cancer. The clinical trial, called ADAURA, tested giving the drug osimertinib (Tagrisso) after surgery in people with early-stage non-small cell lung ...
Repotrectinib Shrinks ROS1-Positive NSCLC Tumors - NCI
Feb 16, 2024 · Treatment with repotrectinib can shrink tumors in people with advanced lung cancer whose tumors have ROS1 fusions. FDA approved the drug in 2023 as an initial or second-line treatment for ROS1-positive NSCLC.
After Four Decades, a Breakthrough for Lung Cancer
Learn about just some of our achievements in this Annual Report. When Karen Milich stopped responding to lung cancer treatments, she enrolled in an MSK-led clinical trial testing a drug that targets the KRAS mutation. The drug, sotorasib, was a breakthrough, 40 years in the making.
FDA Approves New Treatment for Non-Small-Cell Lung Cancer - WebMD
Aug. 21, 2024 – The FDA has approved a new initial treatment for advanced non-small-cell lung cancer after clinical trials showed patients lived longer without disease progression, compared...
Lung Cancer News -- ScienceDaily
6 days ago · Information about lung cancer symptoms and treatments. Explore the latest medical research on cancers including experimental treatments.